Mesoblast Ltd logo

Mesoblast Ltd

MESO
Healthcare|Biotechnology|Australia
$15.46
+0.60 (+4.04%)
Tangible Book
$0.07

Analyst Estimates

annual
{ "date": [ "202606", "202706", "202806", "202906", "203006" ], "revenue_estimate": [ 127.99, 202.76, 296.38, 619.25, 886.44 ], "ebit_estimate": [ -38.69, 19.37, 87.71, 353.72, 571.16 ], "ebitda_estimate": [ null, null, null, null, null ], "net_income_estimate": [ -56.41, 8.87, 77.71, 329.72, 515.75 ], "per_share_eps_estimate": [ -0.44, 0.06, 0.51, 2.12, 3.29 ], "eps_nri_estimate": [ -0.44, 0.06, 0.51, 2.12, 3.29 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -55.78, 8.87, 84.71, 350.72, 568.16 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null ], "gross_margin_estimate": [ 85.9, 87.8, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 257.58, 30.3, 7.31, 4.7 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "128.80", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 128.8, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 9.06, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 6.33, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706" ], "revenue_estimate": [ 36.91, 47.28, 49.34, 51.56, 57.4 ], "ebit_estimate": [ 0.37, 10.19, 10.64, 11.22, 12.27 ], "ebitda_estimate": [ null, null, null, null, null ], "net_income_estimate": [ 0.37, 10.19, 10.64, 11.22, 12.27 ], "per_share_eps_estimate": [ null, 0.08, 0.08, 0.09, 0.07 ], "eps_nri_estimate": [ -0.11, 0.08, 0.08, 0.09, 0.07 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ 0.37, 10.19, 10.64, 11.22, 12.27 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ null, 48.3, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "128.80", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 128.8, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 9.06, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 6.33, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-01 01:25:34